Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1988 Oct;7(5):661-4.
doi: 10.1007/BF01964247.

Ciprofloxacin therapy of respiratory tract infection with Pseudomonas aeruginosa

Affiliations
Comparative Study

Ciprofloxacin therapy of respiratory tract infection with Pseudomonas aeruginosa

M J Haverkorn. Eur J Clin Microbiol Infect Dis. 1988 Oct.

Abstract

Forty-two patients with respiratory tract infection caused by Pseudomonas aeruginosa were treated with 500 mg ciprofloxacin administered orally twice daily. Pseudomonas aeruginosa was eradicated in 22 patients but recurred in eight patients. Clinical improvement or resolution was noted in 37 patients (88%). Eradication and cure rates were highest in patients without permanent risk factors, and in patients with hospital-acquired infection. New colonization during treatment was noted in 14 patients (33%), but no superinfection occurred. In persisting strains of Pseudomonas aeruginosa the in vitro sensitivity to ciprofloxacin decreased significantly during therapy.

PubMed Disclaimer

References

    1. Eur J Clin Microbiol. 1986 Apr;5(2):232-5 - PubMed
    1. Lancet. 1987 May 2;1(8540):1040 - PubMed
    1. J Antimicrob Chemother. 1984 Apr;13(4):333-46 - PubMed
    1. Am J Med. 1987 Apr 27;82(4A):169-73 - PubMed
    1. Lancet. 1986 Apr 12;1(8485):819-22 - PubMed

Publication types